Funding awarded
- Optimization of small molecule immunomodulators as combination therapy for IBD awarded by National Institute of Diabetes & Digestive & Kidney Diseases Key Personnel 2024 - 2029
- Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma awarded by National Cancer Institute Key Personnel 2024 - 2027